Pesquisas

Pesquisar artigos
Palavra chave
FILTROS:
Furoato de mometasona no tratamento de rinite alérgica persistente leve, moderada ou grave: estudo de não inferioridade (PUMA)
Eficácia e segurança da associação fluticasona/formoterol em cápsula única em pacientes com asma persistente: estudo de não inferioridade
ESTUDO FUTURA: Avaliação da eficácia e segurança do fumarato de rupatadina no tratamento da rinite alérgica persistente
Study to Evaluate Efficacy and Safety of Benralizumab in Reducing Oral Corticosteroid Use in Adult Patients with Severe Asthma (PONENTE) (ClinicalTrials.gov Identifier: NCT03557307) – Publicado no The Lancet
Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial (ClinicalTrials.gov Identifier: NCT01928771) – Publicado no The Lancet
Efficacy and safety of fevipiprant in patients with uncontrolled asthma: Two replicate, phase 3, randomised, double-blind, placebo-controlled trials (ZEAL-1 and ZEAL-2) (ClinicalTrials.gov Identifier: NCT03226392) – Publicado no The Lancet
Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma (ClinicalTrials.gov Identifier: NCT03347279) – Publicado no NEJM
A Multi-center, Open-label Extension, Safety Study of Mepolizumab in Subjects With Hypereosinophilic Syndrome (HES) From Study (ClinicalTrials.gov Identifier: NCT03306043) – publicado no JACI: In Practice